Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026)
Stereotaxis' (STXS) quarterly Total Non-Current Liabilities came in at $29.3 million in Q1 2026, down 6.23% year-on-year from $31.3 million in Q1 2025, and up 1.8% on a QoQ basis from $28.8 million in Q4 2025.
Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Total Non-Current Liabilities data on file, last reported at $29.3 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 6.23% year-over-year to $29.3 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 6.23% decrease from a year earlier, with the FY2025 full-year figure at $28.8 million, down 1.23% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $29.3 million, up from $28.8 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for STXS reached as high as $34.7 million in Q3 2024 and fell as low as $19.2 million in Q2 2024.
- Historically, Total Non-Current Liabilities has averaged $25.0 million across 5 years, with a median of $21.4 million in 2022.
- Across the five-year window, Total Non-Current Liabilities declined 10.5% in 2023 and surged 73.53% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $21.4 million in 2022, then slipped by 6.94% to $19.9 million in 2023, then surged by 46.22% to $29.2 million in 2024, then decreased by 1.23% to $28.8 million in 2025, then gained by 1.8% to $29.3 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $29.3 million in Q1 2026, $28.8 million in Q4 2025, and $33.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 29.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.32 Mn |
| Dec 31, 2025 | 28.81 Mn |
| Sep 30, 2025 | 32.95 Mn |
| Jun 30, 2025 | 33.31 Mn |
| Mar 31, 2025 | 31.27 Mn |
| Dec 31, 2024 | 29.17 Mn |
| Sep 30, 2024 | 34.66 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 19.38 Mn |
| Dec 31, 2023 | 19.95 Mn |
| Sep 30, 2023 | 20.19 Mn |
| Jun 30, 2023 | 21.30 Mn |
| Mar 31, 2023 | 21.37 Mn |
| Dec 31, 2022 | 21.43 Mn |
| Sep 30, 2022 | 22.56 Mn |
| Jun 30, 2022 | 20.95 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 21.34 Mn |
| Sep 30, 2021 | 21.55 Mn |
| Jun 30, 2021 | 15.08 Mn |